Daniel Rayson
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer survivorship and care
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 70
- HER2/EGFR in Cancer Research 24
- Cancer Treatment and Pharmacology 17
- Neutropenia and Cancer Infections 7
-
- Breast Cancer Treatment Studies 24
- Co-authors
- Tallal Younis (13 shared papers)Chris Skedgel (19 shared papers)Stephen Chia (15 shared papers)Penny J. Barnes (15 shared papers)T. Younis (22 shared papers)Vera J. Suman (2 shared papers)Lester E. Wold (2 shared papers)Karen A. Gelmon (8 shared papers)
- Journals
- Journal of Clinical Oncology (31 papers)Breast Cancer Research and Treatment (11 papers)The Breast (5 papers)Cancer Research (5 papers)Mayo Clinic Proceedings (5 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Daniel Rayson
132 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 122
- Oncology 1.5k
- Cancer Research 632
- Dermatology 331
- Pathology and Forensic Medicine 339
- Epidemiology 389
Countries citing papers authored by Daniel Rayson
This map shows the geographic impact of Daniel Rayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rayson more than expected).
Fields of papers citing papers by Daniel Rayson
This network shows the impact of papers produced by Daniel Rayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rayson. The network helps show where Daniel Rayson may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 259 | |
| 2 | 2016 | 236 | |
| 3 | 1999 | 179 | |
| 4 | 1998 | 121 | |
| 5 | 2009 | 112 | |
| 6 | 2008 | 100 | |
| 7 | 2015 | 98 | |
| 8 | 2012 | 90 | |
| 9 | 2005 | 88 | |
| 10 | 2008 | 81 | |
| 11 | 2006 | 74 | |
| 12 | 1998 | 74 | |
| 13 | 2014 | 69 | |
| 14 | 2010 | 68 | |
| 15 | 2016 | 67 | |
| 16 | 2006 | 65 | |
| 17 | 2011 | 61 | |
| 18 | 2008 | 58 | |
| 19 | 2000 | 56 | |
| 20 | 2020 | 56 |
About Daniel Rayson
Daniel Rayson is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Epidemiology and Public Health, Environmental and Occupational Health, having authored 139 papers that have together received 3.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (24 papers), Cancer Treatment and Pharmacology (17 papers), Advanced Breast Cancer Therapies (13 papers), Neuroendocrine Tumor Research Advances (10 papers), Neutropenia and Cancer Infections (7 papers), Breast Lesions and Carcinomas (7 papers) and Economic and Financial Impacts of Cancer (7 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (632 citations), Dermatology (331 citations), Pathology and Forensic Medicine (339 citations) and Epidemiology (389 citations). Daniel Rayson has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Tallal Younis, Chris Skedgel, Stephen Chia, Penny J. Barnes, T. Younis, Vera J. Suman, Lester E. Wold, Karen A. Gelmon, Alex A. Adjei and Susan Dent. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, The Breast, Cancer Research and Mayo Clinic Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.